Prescription drug · ANDA
Ondansetron ODT (Ondansetron) NDC 80425-0073
Ondansetron 4 mg/1 · Tablet, Orally disintegrating · Oral · Advanced Rx of Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80425-0073-1 | 80425007301 | 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (80425-0073-1)Marketed from Apr 12, 2010 | |
| 80425-0073-2 | 80425007302 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (80425-0073-2)Marketed from Apr 12, 2010 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ondansetron ODTSuffix: ODT
- Generic name (nonproprietary)
- ondansetron
- Active ingredients
- Ondansetron — 4 mg/1
- Dosage form
- Tablet, Orally disintegrating
- Route
- Oral
- Labeler
- Advanced Rx of Tennessee, LLCNDC labeler code 80425
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090469
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 3 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 80425-0073_2a98d9c1-b777-40b1-e063-6294a90a20e4SPL ID 2a98d9c1-b777-40b1-e063-6294a90a20e4SPL set ID af836a30-5e51-5c97-e053-2995a90a15b9RxCUI 104894UNII 4AF302ESOS
- Pharmacologic class
- Serotonin-3 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480425007301followed by a unit qualifier and the quantityPackage 80425-0073-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. Indications and Usage Section 1 INDICATIONS AND USAGE Ondansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron orally disintegrating tablets also indicated for the prevention of postoperative nausea and/or vomiting.
Excerpt only. Read the full label for complete information.
About NDC 80425-0073
- What is NDC 80425-0073?
- 80425-0073 is the product NDC for Ondansetron ODT (ondansetron), Ondansetron 4 mg/1 tablet, orally disintegrating, listed with the FDA by Advanced Rx of Tennessee, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ondansetron ODT (Ondansetron).
- What is the active ingredient?
- Ondansetron.
- Who is the labeler?
- Advanced Rx of Tennessee, LLC, NDC labeler code 80425. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ondansetron ODT?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 090469
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Northwind Health Company, LLC | 51655-196 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Bryant Ranch Prepack | 71335-1071 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Proficient Rx LP | 63187-379 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Sportpharm LLC | 85766-038 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Aurobindo Pharma Limited | 65862-390 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Aurobindo Pharma Limited | 65862-391 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | HF Acquisition Co LLC, DBA HealthFirst | 51662-1246 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Preferred Pharmaceuticals, Inc. | 68788-7565 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Proficient Rx LP | 71205-713 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | NorthStar Rx LLC | 16714-200 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Preferred Pharmaceuticals, Inc. | 68788-7644 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Bryant Ranch Prepack | 71335-0650 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | NorthStar Rx LLC | 16714-201 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | NuCare Pharmaceuticals,Inc. | 68071-4834 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | REMEDYREPACK INC. | 70518-1551 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | A-S Medication Solutions | 50090-1128 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | NuCare Pharmaceuticals,Inc. | 68071-4881 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Rising Pharma Holdings, Inc. | 57237-077 |
| Ondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | A-S Medication Solutions | 50090-2343 |
| Ondansetron | Ondansetron 8 mg/1 | Tablet, Orally disintegratingOral | Rising Pharma Holdings, Inc. | 57237-078 |
Showing 20 of 39.